BIOMAT Database Logo BIOMAT Database Logo

Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial. 2013

F Siebenhaar, and A Förtsch, and K Krause, and K Weller, and M Metz, and M Magerl, and P Martus, and M K Church, and M Maurer
Department of Dermatology and Allergy, Interdisciplinary Mastocytosis Center Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany. frank.siebenhaar@charite.de

BACKGROUND Mastocytosis is frequently associated with mast cell-mediated symptoms which require relieving medication. While second generation antihistamines (sgAHs) are the first line therapeutic strategy to treat mast cell mediator-related symptoms, controlled clinical trials on how they improve quality of life have not been performed. METHODS This randomized, double-blind, placebo-controlled, cross-over trial assessed rupatadine 20 mg daily in the treatment of mastocytosis symptoms in 30 adult patients. Symptoms were assessed by a visual analogue scale (VAS) and symptom specific quality of life questionnaire (ItchyQoL). RESULTS The mean ItchyQoL total score and VAS symptom score were significantly improved in the rupatadine treatment phase compared with placebo. There were also significant reductions from placebo in the severity of itch, wheal and flare, flushing, tachycardia and headache but not gastrointestinal symptoms. CONCLUSIONS In this first comprehensive trial of a sgAH in mastocytosis, rupatadine 20 mg daily for 4 weeks significantly controlled symptoms and improved patients' quality of life.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D003533 Cyproheptadine A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc. Antergan,Dihexazin,Periactin,Peritol,Viternum
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

F Siebenhaar, and A Förtsch, and K Krause, and K Weller, and M Metz, and M Magerl, and P Martus, and M K Church, and M Maurer
Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain: A Randomized, Double-Blind, Placebo-Controlled Trial.
June 2023, Nutrients,
F Siebenhaar, and A Förtsch, and K Krause, and K Weller, and M Metz, and M Magerl, and P Martus, and M K Church, and M Maurer
Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trial.
April 2023, Hepatology international,
F Siebenhaar, and A Förtsch, and K Krause, and K Weller, and M Metz, and M Magerl, and P Martus, and M K Church, and M Maurer
Fermented soy supplementation improves indicators of quality of life: a randomized, placebo-controlled, double-blind trial in adults experiencing heartburn.
August 2020, BMC research notes,
F Siebenhaar, and A Förtsch, and K Krause, and K Weller, and M Metz, and M Magerl, and P Martus, and M K Church, and M Maurer
Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo-controlled trial.
June 2004, Epilepsy & behavior : E&B,
F Siebenhaar, and A Förtsch, and K Krause, and K Weller, and M Metz, and M Magerl, and P Martus, and M K Church, and M Maurer
Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial.
October 1993, The British journal of dermatology,
F Siebenhaar, and A Förtsch, and K Krause, and K Weller, and M Metz, and M Magerl, and P Martus, and M K Church, and M Maurer
Dietary supplementation and quality of life of older patients: a randomized, double-blind, placebo-controlled trial.
December 2007, Journal of the American Geriatrics Society,
F Siebenhaar, and A Förtsch, and K Krause, and K Weller, and M Metz, and M Magerl, and P Martus, and M K Church, and M Maurer
A double-blind randomized placebo-controlled trial of sibutramine.
May 1996, Obesity research,
F Siebenhaar, and A Förtsch, and K Krause, and K Weller, and M Metz, and M Magerl, and P Martus, and M K Church, and M Maurer
Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study.
May 2007, Allergy,
F Siebenhaar, and A Förtsch, and K Krause, and K Weller, and M Metz, and M Magerl, and P Martus, and M K Church, and M Maurer
Marfan Sartan: a randomized, double-blind, placebo-controlled trial.
August 2015, European heart journal,
F Siebenhaar, and A Förtsch, and K Krause, and K Weller, and M Metz, and M Magerl, and P Martus, and M K Church, and M Maurer
Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
September 2017, Therapeutic advances in gastroenterology,
Copied contents to your clipboard!